Organon & Co.OGN

Market cap
$1.9B
P/E ratio
Dec 31,
2021
Dec 31,
2022
Dec 31,
2023
Dec 31,
2024
Cash and cash equivalents737706693675
Accounts Receivable, after Allowance for Credit Loss, Current1,3821,4751,7441,358
Inventory, Net9151,0031,3151,321
Other current assets726747756994
Total Current Assets3,7603,9314,5084,348
Property, plant and equipment, net9731,0181,1831,168
Goodwill4,6034,6034,6034,680
Intangibles, net6516495331,414
Other assets6947541,2311,491
Total Assets10,68110,95512,05813,101
Current portion of long-term debt98920
Trade accounts payable1,3821,1321,3141,153
Accrued and other current liabilities1,0211,1881,3891,411
Income taxes payable185184206134
Total Current Liabilities2,5972,5122,9182,718
Long-term debt9,1258,9058,7518,860
Deferred income taxes4194774
Other noncurrent liabilities463411412977
Total Liabilities--12,12812,629
Common Stock, Value, Issued3333
Additional paid-in capital--25108
Retained earnings-998-3314431,010
Accumulated other comprehensive loss-513-564-541-649
Total Stockholders’ Equity (Deficit)-1,508-892-70472
Total Liabilities and Stockholders’ Equity (Deficit)10,68110,95512,05813,101